361 related articles for article (PubMed ID: 27240017)
1. Relationship between selected oxidative stress markers and lipid risk factors for cardiovascular disease in middle-aged adults and its possible clinical relevance.
Viktorinova A; Svitekova K; Stecova A; Krizko M
Clin Biochem; 2016 Aug; 49(12):868-72. PubMed ID: 27240017
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes.
Viktorinova A; Jurkovicova I; Fabryova L; Kinova S; Koren M; Stecova A; Svitekova K
Diabetes Res Clin Pract; 2018 Jun; 140():174-182. PubMed ID: 29626583
[TBL] [Abstract][Full Text] [Related]
3. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
[TBL] [Abstract][Full Text] [Related]
4. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
Göçmen AY; Gümüşlü S; Semiz E
Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
[TBL] [Abstract][Full Text] [Related]
5. High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus.
Gaál K; Tarr T; Lőrincz H; Borbás V; Seres I; Harangi M; Fülöp P; Paragh G
Lipids Health Dis; 2016 Mar; 15():60. PubMed ID: 27004558
[TBL] [Abstract][Full Text] [Related]
6. Serum Amyloid A, Paraoxonase-1 Activity, and Apolipoprotein Concentrations as Biomarkers of Subclinical Atherosclerosis Risk in Adrenal Incidentaloma Patients.
Imga NN; Topcuoglu C; Berker D; Turhan T
Arch Med Res; 2018 Apr; 49(3):182-190. PubMed ID: 30031631
[TBL] [Abstract][Full Text] [Related]
7. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
[TBL] [Abstract][Full Text] [Related]
8. Serum paraoxonase enzyme activity and oxidative stress in obese subjects.
Aslan M; Horoz M; Sabuncu T; Celik H; Selek S
Pol Arch Med Wewn; 2011 Jun; 121(6):181-6. PubMed ID: 21694681
[TBL] [Abstract][Full Text] [Related]
9. Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients.
Tomás M; Sentí M; García-Faria F; Vila J; Torrents A; Covas M; Marrugat J
Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2113-9. PubMed ID: 10978257
[TBL] [Abstract][Full Text] [Related]
10. Paraoxonase-1 and oxidized lipoprotein lipids. The Cardiovascular Risk in Young Finns Study.
Kresanov P; Vasankari T; Ahotupa M; Kaikkonen J; Hutri-Kähönen N; Juonala M; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT
Atherosclerosis; 2015 Aug; 241(2):502-6. PubMed ID: 26091975
[TBL] [Abstract][Full Text] [Related]
11. Oxidative status and serum PON1 activity in beta-thalassemia minor.
Selek S; Aslan M; Horoz M; Gur M; Erel O
Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
[TBL] [Abstract][Full Text] [Related]
12. Paraoxonase, a cardioprotective enzyme: continuing issues.
Getz GS; Reardon CA
Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
[TBL] [Abstract][Full Text] [Related]
13. Altered lipid subfraction profile and impaired antioxidant defense of high-density lipoprotein in Smith-Lemli-Opitz syndrome.
Lőrincz H; Harangi M; Oláh AV; Szabó GP; Fülöp P; Somodi S; Paragh G; Seres I
Pediatr Res; 2015 May; 77(5):703-9. PubMed ID: 25668223
[TBL] [Abstract][Full Text] [Related]
14. Postprandial Paraoxonase 1 Activity Following Consumption of Recommended Amounts of Mixed Meals in Healthy Males.
Kameyama N; Maruyama C; Kotani K; Caccavello R; Gugliucci A; Matsui S; Araki R; Maruyama T
J Atheroscler Thromb; 2016; 23(2):225-32. PubMed ID: 26447089
[TBL] [Abstract][Full Text] [Related]
15. Comparison of early cardiovascular risk among Brazilian and African university students.
de Sousa ELH; Cavalcante JEA; de Sousa DF; Ferreira JM; Meneses RRC; Sousa DL; da Silva AJX; Filho RRBX; da Silva Dos Santos E; Havt A; Damasceno NRT; Sampaio TL; Queiroz MGR
Clin Biochem; 2020 Jan; 75():7-14. PubMed ID: 31678428
[TBL] [Abstract][Full Text] [Related]
16. PON1 arylesterase activity, HDL functionality and their correlation in malnourished children.
Mogarekar MR; Dhabe MG; Palmate MM
J Pediatr Endocrinol Metab; 2019 Apr; 32(4):321-326. PubMed ID: 30875327
[TBL] [Abstract][Full Text] [Related]
17. Gender related differences in paraoxonase 1 response to high-fat diet-induced oxidative stress.
Thomàs-Moyà E; Gómez-Pérez Y; Fiol M; Gianotti M; Lladó I; Proenza AM
Obesity (Silver Spring); 2008 Oct; 16(10):2232-8. PubMed ID: 18719679
[TBL] [Abstract][Full Text] [Related]
18. Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects.
Vekic J; Kotur-Stevuljevic J; Jelic-Ivanovic Z; Spasic S; Spasojevic-Kalimanovska V; Topic A; Zeljkovic A; Stefanovic A; Zunic G
Eur J Clin Invest; 2007 Sep; 37(9):715-23. PubMed ID: 17696961
[TBL] [Abstract][Full Text] [Related]
19. Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus.
Shen Y; Ding FH; Sun JT; Pu LJ; Zhang RY; Zhang Q; Chen QJ; Shen WF; Lu L
Cardiovasc Diabetol; 2015 May; 14():52. PubMed ID: 25964115
[TBL] [Abstract][Full Text] [Related]
20. Paraoxonase-1 arylesterase activity is an independent predictor of myeloperoxidase levels in overweight patients with or without cardiovascular complications.
Zsíros N; Koncsos P; Lőrincz H; Seres I; Katkó M; Szentpéteri A; Varga VE; Fülöp P; Paragh G; Harangi M
Clin Biochem; 2016 Aug; 49(12):862-7. PubMed ID: 27129797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
